Difference between revisions of "Fluoxetine-mirtazapine"

From Psychiatrienet
Jump to: navigation, search
 
(5 intermediate revisions by 2 users not shown)
Line 3: Line 3:
 
| to = mirtazapine
 
| to = mirtazapine
 
| stop =  
 
| stop =  
* Gradually reduce dosage of fluoxetine to a maximum of 20 mg/ day, when this dosage is > 20 mg/day.
+
{{stopfluox}}
* When a dosage of 20 mg/day is reached, stop administration.
 
 
| start =  
 
| start =  
No wash-out period is needed.
+
{{startnafluox}}
* '''Day 1:''' start mirtazapine the next day in low dosage of 15 mg/day.
 
* '''Day 21:''' increase dosage of mirtazapine to normal, 30 mg/day.
 
 
| info =  
 
| info =  
* (Desmethyl)Fluoxetine has a very long elimination time; phasing out fluoxetine is therefore not necessary.
+
*Safe target dose mirtazapine = 15 mg
{{review}}
+
{{longt1/2fluvox}}
 
}}
 
}}

Latest revision as of 15:41, 24 February 2023

Fluoxetine
Type Antidepressant
Group SSRI
links
Medscape Fluoxetine
PubChem 3386
PubMed Fluoxetine
Kompas (Dutch) Fluoxetine
Wikipedia Fluoxetine
Mirtazapine
Type Antidepressant
Group other
links
Medscape Mirtazapine
PubChem 4205
PubMed Mirtazapine
Kompas (Dutch) Mirtazapine
Wikipedia Mirtazapine

Switch medication from fluoxetine to mirtazapine.[1] [2]

Nietinrijdenbord.png Stop fluoxetine
  • Day 1: Stop fluoxetine
Eenrichtingbord.png Start mirtazapine
  • Day 5: Start with 50% of the target dose
  • Day 10: Increase dose to 100% of the target dose
  • Day 11 and after: Gradually increase dose as necessary
Infobord.png More information
  • Safe target dose mirtazapine = 15 mg
  • Fluoxetine and its metababolite desmethyl-fluoxetine have a very long elimination time of about 1 week; phasing out fluoxetine is therefore not necessary.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.